DEFECTIVE LIPOPOLYSACCHARIDE-INDUCED PRODUCTION OF BOTH INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-ALPHA BY A/J MOUSE MACROPHAGES IS POSTTRANSCRIPTIONALLY REGULATED

被引:7
作者
BRANDWEIN, SR
MAENZ, L
机构
[1] MCGILL UNIV,MONTREAL GEN HOSP,RES INST,MONTREAL H3G 1A4,QUEBEC,CANADA
[2] MCGILL UNIV,DEPT MED,DIV RHEUMATOL,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
KEY WORDS; GENE EXPRESSION; SYNTHESIS; PROCESSING;
D O I
10.1002/jlb.51.6.570
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin 1 (IL-1) production by A/J (A) and C57BL/6J (B6) mouse peritoneal macrophages stimulated with lipopolysaccharide (LPS) was determined. Strain A macrophages produced low levels of soluble IL-1 bioactivity compared with B6 macrophages. This defect was not reversed by indomethacin, interferon-gamma, phorbol myristate acetate, or calcium ionophore A23187. In contrast, cytosolic IL-1 bioactivity was similar in LPS-stimulated A and B6 macrophages. Western blotting revealed that A macrophage supernatants contained lower levels of both 17-kd IL-1alpha and 17-kd IL-1beta but similar levels of tumor necrosis factor alpha compared with B6 macrophages. Cytosolic levels of 31-kd pro-IL-1alpha and also 31-kd pro-IL-1beta were similar in A and B6 macrophages. Oligonucleotide probing indicated that A and B6 macrophages contained similar levels of IL-1alpha and also IL-1beta mRNA. These findings indicate that LPS-stimulated A macrophage culture supernatants contain low levels of both IL-1alpha and IL-1beta compared with B6 macrophages and that these defects in IL-1 production are posttranscriptionally regulated.
引用
收藏
页码:570 / 578
页数:9
相关论文
共 47 条
[1]  
AMENTO EP, 1985, J IMMUNOL, V134, P350
[2]  
BAKOUCHE O, 1987, J IMMUNOL, V138, P4249
[3]  
BEUSCHER HU, 1990, J IMMUNOL, V144, P2179
[4]   STRUCTURE AND FUNCTION OF MEMBRANE IL-1 [J].
BEUSCHER, HU ;
COLTEN, HR .
MOLECULAR IMMUNOLOGY, 1988, 25 (11) :1189-1199
[5]  
BLACK RA, 1988, J BIOL CHEM, V263, P9437
[6]  
BORASCHI D, 1983, J IMMUNOL, V131, P1707
[7]  
BORASCHI D, 1984, J IMMUNOL, V133, P764
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   DIFFERENTIAL REGULATION OF SOLUBLE INTERLEUKIN-1 RELEASE AND MEMBRANE EXPRESSION BY PHARMACOLOGICAL AGENTS [J].
BRANDWEIN, SR .
AGENTS AND ACTIONS, 1990, 30 (3-4) :381-392
[10]  
BRANDWEIN SR, 1987, J IMMUNOL, V138, P4263